ClariTrial | Search Clinical Trials

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

590 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Phase 3Venous ThromboembolismBlood ClotPost Thrombotic Syndrome

Rosuvastatin CalciumPlacebo Oral Tablet

Ottawa Hospital Research Institute2,700 participants31 sites · Canada, France, IrelandCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Phase 3Multiple Myeloma

Ixazomib, thalidomide, & dexamethasone (ITD) re-inductionConventional autologous stem cell transplant (ASCT-con)Augmented autologous stem cell transplant (ASCT-aug)+1 more

University of Leeds406 participants91 sites · United KingdomCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Phase 3MYOCARDIAL INFARCTION

single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.

Assistance Publique - Hôpitaux de Paris2,468 participants1 site · FranceCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Phase 3Chronic Kidney Disease and Hypertension

Baxdrostat/dapagliflozinPlacebo/dapagliflozin

AstraZeneca5,000 participants771 sites · United States, Argentina, AustraliaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

tDCS for Post-Stroke Cognitive Impairment

Phase 2StrokeMild Cognitive Impairment

Transcranial Dirrect Current Stimulation

University of Oklahoma80 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 2 Study of CRD-4730 in CPVT

Phase 2Catecholaminergic Polymorphic Ventricular Tachycardia

CRD-4730Placebo

Cardurion Pharmaceuticals, Inc.12 participants12 sites · United States, Canada, FranceCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support

Phase 2Heart FailureMechanical Circulatory Support

CD34+ stem cell therapy

University Medical Centre Ljubljana10 participants1 site · SloveniaCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Omega-3D: Omega-3 for Diet-Driven Health Disparities

Phase 2Heart Health MarkersCardiovascular DiseasesOmega 3 Fatty Acids

Omega-3 Fatty Acids and Safflower Oil PlaceboSafflower Oil Placebo and Omega-3 Fatty Acids

University of Arizona200 participants2 sites · United StatesCompletes May 2029

Compare CT.gov Full analysis →

Recruiting

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

Phase 2Heart FailureAcute Kidney Injury

Dapagliflozin 10mg TabPlacebo

Yale University130 participants2 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab

Phase 2Cryoglobulinemic Vasculitis (CV)

Obinutuzumab

Assistance Publique - Hôpitaux de Paris30 participants25 sites · FranceCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Phase 3Tachycardia AtrialAtrial FibrillationAtrial Flutter With Rapid Ventricular Response

Magnesium Sulfate 2 GMagnesium Sulfate 4 GSaline

Wake Forest University Health Sciences153 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

Phase 2Chronic Kidney Disease

Sodium BicarbonateExercise TrainingPlacebo

Emory University156 participants2 sites · United StatesCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

Phase 2Atrial Fibrillation

BAY 3670549Placebo

Bayer360 participants29 sites · United States, Belgium, BulgariaCompletes May 2030

Compare CT.gov Full analysis →

Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Phase 3Aortic DissectionInflammation

Ketorolac0.9 % saline

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1,346 participants1 site · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Phase 1Phase 2Malignant Digestive System Neoplasm

Biospecimen CollectionCapecitabineDiltiazem Hydrochloride+7 more

Mayo Clinic60 participants1 site · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

1–15 of 590

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

590 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Phase 3Venous ThromboembolismBlood ClotPost Thrombotic Syndrome

Rosuvastatin CalciumPlacebo Oral Tablet

Ottawa Hospital Research Institute2,700 participants31 sites · Canada, France, IrelandCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Phase 3Multiple Myeloma

Ixazomib, thalidomide, & dexamethasone (ITD) re-inductionConventional autologous stem cell transplant (ASCT-con)Augmented autologous stem cell transplant (ASCT-aug)+1 more

University of Leeds406 participants91 sites · United KingdomCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Phase 3MYOCARDIAL INFARCTION

single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.

Assistance Publique - Hôpitaux de Paris2,468 participants1 site · FranceCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Phase 3Chronic Kidney Disease and Hypertension

Baxdrostat/dapagliflozinPlacebo/dapagliflozin

AstraZeneca5,000 participants771 sites · United States, Argentina, AustraliaCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

tDCS for Post-Stroke Cognitive Impairment

Phase 2StrokeMild Cognitive Impairment

Transcranial Dirrect Current Stimulation

University of Oklahoma80 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 2 Study of CRD-4730 in CPVT

Phase 2Catecholaminergic Polymorphic Ventricular Tachycardia

CRD-4730Placebo

Cardurion Pharmaceuticals, Inc.12 participants12 sites · United States, Canada, FranceCompletes Apr 2027

Compare CT.gov Full analysis →

Recruiting

Cell Therapy and Myocardial Recovery in Heart Failure Patients Undergoing Left Ventricular Assist Device Support

Phase 2Heart FailureMechanical Circulatory Support

CD34+ stem cell therapy

University Medical Centre Ljubljana10 participants1 site · SloveniaCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

Omega-3D: Omega-3 for Diet-Driven Health Disparities

Phase 2Heart Health MarkersCardiovascular DiseasesOmega 3 Fatty Acids

Omega-3 Fatty Acids and Safflower Oil PlaceboSafflower Oil Placebo and Omega-3 Fatty Acids

University of Arizona200 participants2 sites · United StatesCompletes May 2029

Compare CT.gov Full analysis →

Recruiting

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome

Phase 2Heart FailureAcute Kidney Injury

Dapagliflozin 10mg TabPlacebo

Yale University130 participants2 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Phase 2Cryoglobulinemic Vasculitis (CV)

Obinutuzumab

Assistance Publique - Hôpitaux de Paris30 participants25 sites · FranceCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR

Phase 3Tachycardia AtrialAtrial FibrillationAtrial Flutter With Rapid Ventricular Response

Magnesium Sulfate 2 GMagnesium Sulfate 4 GSaline

Wake Forest University Health Sciences153 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

Phase 2Chronic Kidney Disease

Sodium BicarbonateExercise TrainingPlacebo

Emory University156 participants2 sites · United StatesCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

Phase 2Atrial Fibrillation

BAY 3670549Placebo

Bayer360 participants29 sites · United States, Belgium, BulgariaCompletes May 2030

Compare CT.gov Full analysis →

Recruiting

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Phase 3Aortic DissectionInflammation

Ketorolac0.9 % saline

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1,346 participants1 site · ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Phase 1Phase 2Malignant Digestive System Neoplasm

Biospecimen CollectionCapecitabineDiltiazem Hydrochloride+7 more

Mayo Clinic60 participants1 site · United StatesCompletes Apr 2028

Compare CT.gov Full analysis →

1–15 of 590